{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T22:24:45Z","timestamp":1773095085463,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Disseminated intravascular coagulation (DIC) is one of the major organ dysfunctions associated with sepsis. This retrospective secondary analysis comprised data from a prospective multicenter study to investigate the age-related differences in the survival benefit of anticoagulant therapy in sepsis according to the DIC diagnostic criteria. Adult patients with severe sepsis based on the Sepsis-2 criteria were enrolled and divided into the following groups: (1) anticoagulant group (patients who received anticoagulant therapy) and (2) non-anticoagulant group (patients who did not receive anticoagulant therapy). Patients in the former group were administered antithrombin, recombinant human thrombomodulin, or their combination. The increases in the risk of hospital mortality were suppressed in the high-DIC-score patients aged 60\u201370\u00a0years receiving anticoagulant therapy. No favorable association of anti-coagulant therapy with hospital mortality was observed in patients aged 50\u00a0years and 80\u00a0years. Furthermore, anticoagulant therapy in the lower-DIC-score range increased the risk of hospital mortality in patients aged 50\u201360\u00a0years. In conclusion, anticoagulant therapy was associated with decreased hospital mortality according to a higher DIC score in septic patients aged 60\u201370\u00a0years. Anticoagulant therapy, however, was not associated with a better outcome in relatively younger and older patients with sepsis.<\/jats:p>","DOI":"10.1038\/s41598-022-13346-3","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T17:02:48Z","timestamp":1654275768000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Age-related differences in the survival benefit of the administration of antithrombin, recombinant human thrombomodulin, or their combination in sepsis"],"prefix":"10.1038","volume":"12","author":[{"given":"Takeshi","family":"Wada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuma","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daijiro","family":"Kabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshikazu","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daizoh","family":"Saitoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Kushimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seitaro","family":"Fujishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Mayumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Hifumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasukazu","family":"Shiino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taka-aki","family":"Nakada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiko","family":"Tarui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Otomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohji","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joji","family":"Kotani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ichiro","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyotsugu","family":"Takuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Tsuruta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyoshi","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Masuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoshi","family":"Takeyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroto","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Ueyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Fujimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Gando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,3]]},"reference":[{"key":"13346_CR1","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1055\/s-0037-1616068","volume":"86","author":"FB Taylor Jr","year":"2001","unstructured":"Taylor, F. B. Jr. et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb. Haemost. 86, 1327\u20131330 (2001).","journal-title":"Thromb. Haemost."},{"key":"13346_CR2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.7326\/0003-4819-115-6-457","volume":"115","author":"RC Bone","year":"1991","unstructured":"Bone, R. C. The pathogenesis of sepsis. Ann. Intern. Med. 115, 457\u2013469 (1991).","journal-title":"Ann. Intern. Med."},{"key":"13346_CR3","doi-asserted-by":"publisher","first-page":"16037","DOI":"10.1038\/nrdp.2016.37","volume":"2","author":"S Gando","year":"2016","unstructured":"Gando, S., Levi, M. & Toh, C.-H. Disseminated intravascular coagulation. Nat. Rev. Dis. Primers. 2, 16037 (2016).","journal-title":"Nat. Rev. Dis. Primers."},{"key":"13346_CR4","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1097\/CCM.0b013e31819c06bc","volume":"37","author":"F Jaimes","year":"2009","unstructured":"Jaimes, F. et al. Unfractioned heparin for treatment of sepsis: A randomized clinical trial (The HETRASE Study). Crit. Care Med. 37, 1185\u20131196 (2009).","journal-title":"Crit. Care Med."},{"key":"13346_CR5","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1001\/jama.286.15.1869","volume":"286","author":"BL Warren","year":"2001","unstructured":"Warren, B. L. et al. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: A randomized controlled trial. JAMA 286, 1869\u20131878 (2001).","journal-title":"JAMA"},{"key":"13346_CR6","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJM200103083441001","volume":"344","author":"GR Bernard","year":"2001","unstructured":"Bernard, G. R. et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344, 699\u2013709 (2001).","journal-title":"N. Engl. J. Med."},{"key":"13346_CR7","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1056\/NEJMoa050935","volume":"353","author":"E Abraham","year":"2005","unstructured":"Abraham, E. et al. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N. Engl. J. Med. 353, 1332\u20131341 (2005).","journal-title":"N. Engl. J. Med."},{"key":"13346_CR8","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1056\/NEJMoa1202290","volume":"366","author":"VM Ranieri","year":"2012","unstructured":"Ranieri, V. M. et al. Drotrecogin alfa (activated) in adults with septic shock. N. Engl. J. Med. 366, 2055\u20132064 (2012).","journal-title":"N. Engl. J. Med."},{"key":"13346_CR9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1001\/jama.290.2.238","volume":"290","author":"E Abraham","year":"2003","unstructured":"Abraham, E. et al. Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: A randomized controlled trial. JAMA 290, 238\u2013247 (2003).","journal-title":"JAMA"},{"key":"13346_CR10","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1164\/rccm.201007-1167OC","volume":"183","author":"RG Wunderink","year":"2011","unstructured":"Wunderink, R. G. et al. Recombinant tissue factor pathway inhibitor in severe community-acquired pneumonia: A randomized trial. Am. J. Respir. Crit. Care Med. 183, 1561\u20131568 (2011).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"13346_CR11","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1001\/jama.2019.5358","volume":"321","author":"J-L Vincent","year":"2019","unstructured":"Vincent, J.-L. et al. Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: The SCARLET randomized clinical trial. JAMA 321, 1993\u20132002 (2019).","journal-title":"JAMA"},{"key":"13346_CR12","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/S2213-2600(17)30268-0","volume":"5","author":"D Grimaldi","year":"2017","unstructured":"Grimaldi, D. & Vincent, J.-L. Clinical trial research in focus: Rethinking trials in sepsis. Lancet Respir. Med. 5, 610\u2013611 (2017).","journal-title":"Lancet Respir. Med."},{"key":"13346_CR13","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/jth.13946","volume":"16","author":"Y Umemura","year":"2018","unstructured":"Umemura, Y. & Yamakawa, K. Optimal patient selection for anticoagulant therapy in sepsis: An evidence-based proposal from Japan. J. Thromb. Haemost. 16, 462\u2013464 (2018).","journal-title":"J. Thromb. Haemost."},{"key":"13346_CR14","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1055\/s-0039-1693740","volume":"119","author":"K Yamakawa","year":"2019","unstructured":"Yamakawa, K. et al. Identifying sepsis populations benefitting from anticoagulant therapy: A prospective cohort study incorporating a restricted cubic spline regression model. Thromb. Haemost. 119, 1740\u20131751 (2019).","journal-title":"Thromb. Haemost."},{"key":"13346_CR15","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","volume":"13","author":"WA Knaus","year":"1985","unstructured":"Knaus, W. A., Draper, E. A., Wagner, D. P. & Zimmerman, J. E. APACHE II: A severity of disease classification system. Crit. Care Med. 13, 818\u2013829 (1985).","journal-title":"Crit. Care Med."},{"key":"13346_CR16","doi-asserted-by":"publisher","first-page":"R111","DOI":"10.1186\/cc12783","volume":"17","author":"S Gando","year":"2013","unstructured":"Gando, S. et al. A multicenter, prospective validation study of the Japanese Association for Acute Medicine disseminated intravascular coagulation scoring system in patients with severe sepsis. Crit. Care. 17, R111 (2013).","journal-title":"Crit. Care."},{"key":"13346_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/ams2.372","volume":"6","author":"T Iba","year":"2019","unstructured":"Iba, T. et al. Diagnosis of sepsis-induced disseminated intravascular coagulation and coagulopathy. Acute Med. Surg. 6, 223\u2013232 (2019).","journal-title":"Acute Med. Surg."},{"key":"13346_CR18","first-page":"82","volume":"65","author":"S Delibegovic","year":"2011","unstructured":"Delibegovic, S., Markovic, D. & Hodzic, S. APACHE II scoring system is superior in the prediction of the outcome in critically ill patients with perforative peritonitis. Med. Arh. 65, 82\u201385 (2011).","journal-title":"Med. Arh."},{"key":"13346_CR19","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1055\/s-2002-36700","volume":"28","author":"WR Wilkerson","year":"2002","unstructured":"Wilkerson, W. R. & Sane, D. C. Aging and thrombosis. Semin. Thromb. Hemost. 28, 555\u2013568 (2002).","journal-title":"Semin. Thromb. Hemost."},{"key":"13346_CR20","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.thromres.2019.04.025","volume":"178","author":"S Gando","year":"2019","unstructured":"Gando, S. et al. Role of disseminated intravascular coagulation in severe sepsis. Thromb. Res. 178, 182\u2013188 (2019).","journal-title":"Thromb. Res."},{"key":"13346_CR21","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.thromres.2017.11.023","volume":"161","author":"Y Umemura","year":"2018","unstructured":"Umemura, Y., Yamakawa, K., Hayakawa, M., Hamasaki, T. & Fujimi, S. Japan Septic Disseminated Intravascular Coagulation (J-Septic DIC) study group. Screening itself for disseminated intravascular coagulation may reduce mortality in sepsis: A nationwide multicenter registry in Japan. Thromb. Res. 161, 60\u201366 (2018).","journal-title":"Thromb. Res."},{"key":"13346_CR22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1538-7836.2005.01697.x","volume":"4","author":"J Kienast","year":"2006","unstructured":"Kienast, J. et al. Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J. Thromb. Haemost. 4, 90\u201397 (2006).","journal-title":"J. Thromb. Haemost."},{"key":"13346_CR23","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/jth.13230","volume":"14","author":"Y Umemura","year":"2016","unstructured":"Umemura, Y., Yamakawa, K., Ogura, H., Yuhara, H. & Fujimi, S. Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: A meta-analysis of randomized controlled trials. J. Thromb. Haemost. 14, 518\u2013530 (2016).","journal-title":"J. Thromb. Haemost."},{"key":"13346_CR24","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s13054-016-1415-1","volume":"20","author":"K Yamakawa","year":"2016","unstructured":"Yamakawa, K. et al. Benefit profile of anticoagulant therapy in sepsis: A nationwide multicentre registry in Japan. Crit. Care. 20, 229 (2016).","journal-title":"Crit. Care."},{"key":"13346_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13054-015-0810-3","volume":"19","author":"J Yoshimura","year":"2015","unstructured":"Yoshimura, J. et al. Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: A multicenter propensity score analysis. Crit. Care. 19, 78 (2015).","journal-title":"Crit. Care."},{"key":"13346_CR26","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd, K. E. et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: Analysis for the Global Burden of Disease Study. Lancet 395, 200\u2013211 (2020).","journal-title":"Lancet"},{"key":"13346_CR27","first-page":"126","volume":"5","author":"ME Starr","year":"2014","unstructured":"Starr, M. E. & Saito, H. Sepsis in old age: Review of human and animal studies. Aging Dis. 5, 126\u2013136 (2014).","journal-title":"Aging Dis."},{"key":"13346_CR28","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","volume":"29","author":"DC Angus","year":"2001","unstructured":"Angus, D. C. et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29, 1303\u20131310 (2001).","journal-title":"Crit. Care Med."},{"key":"13346_CR29","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.exger.2008.05.016","volume":"43","author":"CR Gomez","year":"2008","unstructured":"Gomez, C. R., Nomellini, V., Faunce, D. E. & Kovacs, E. J. Innate immunity and aging. Exp. Gerontol. 43, 718\u2013728 (2008).","journal-title":"Exp. Gerontol."},{"key":"13346_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00281-001-0094-3","volume":"24","author":"ME Weksler","year":"2002","unstructured":"Weksler, M. E., Goodhardt, M. & Szabo, P. The effect of age on B cell development and humoral immunity. Springer Semin. Immunopathol. 24, 35\u201352 (2002).","journal-title":"Springer Semin. Immunopathol."},{"key":"13346_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013852","volume":"5","author":"S Kale","year":"2010","unstructured":"Kale, S. et al. The effects of age on inflammatory and coagulation-fibrinolysis response in patients hospitalized for pneumonia. PLoS ONE 5, e13852 (2010).","journal-title":"PLoS ONE"},{"key":"13346_CR32","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.ajem.2013.06.011","volume":"31","author":"M Naffaa","year":"2013","unstructured":"Naffaa, M. et al. Interleukin-6 at discharge predicts all-cause mortality in patients with sepsis. Am. J. Emerg. Med. 31, 1361\u20131364 (2013).","journal-title":"Am. J. Emerg. Med."},{"key":"13346_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1046\/j.1532-5415.2001.49003.x","volume":"49","author":"PE Marik","year":"2001","unstructured":"Marik, P. E. & Zaloga, G. P. NORASEPT II Study Investigators. North American Sepsis Trial II. The effect of aging on circulating levels of proinflammatory cytokines during septic shock. Norasept II Study Investigators. J. Am. Geriatr. Soc. 49, 5\u20139 (2001).","journal-title":"J. Am. Geriatr. Soc."},{"key":"13346_CR34","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1086\/314873","volume":"180","author":"H Bruunsgaard","year":"1999","unstructured":"Bruunsgaard, H., Skinh\u00f8j, P., Qvist, J. & Pedersen, B. K. Elderly humans show prolonged in vivo inflammatory activity during pneumococcal infections. J. Infect. Dis. 180, 551\u2013554 (1999).","journal-title":"J. Infect. Dis."},{"key":"13346_CR35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri3345","volume":"13","author":"B Engelmann","year":"2013","unstructured":"Engelmann, B. & Massberg, S. Thrombosis as an intravascular effector of innate immunity. Nat. Rev. Immunol. 13, 34\u201345 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"13346_CR36","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s13054-018-2186-7","volume":"22","author":"T Abe","year":"2018","unstructured":"Abe, T. et al. Characteristics, management, and in-hospital mortality among patients with severe sepsis in intensive care units in Japan: The FORECAST study. Crit. Care. 22, 322 (2018).","journal-title":"Crit. Care."},{"key":"13346_CR37","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s00134-003-1662-x","volume":"29","author":"MM Levy","year":"2003","unstructured":"Levy, M. M. et al. 2001 SCCM\/ESICM\/ACCP\/ATS\/SIS international sepsis definitions conference. Intensive Care Med. 29, 530\u2013538 (2003).","journal-title":"Intensive Care Med."},{"key":"13346_CR38","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40560-021-00555-7","volume":"9","author":"M Egi","year":"2021","unstructured":"Egi, M. et al. The Japanese clinical practice guidelines for management of sepsis and septic shock 2020 (J-SSCG 2020). J. Intensive Care. 9, 53 (2021).","journal-title":"J. Intensive Care."},{"key":"13346_CR39","doi-asserted-by":"crossref","unstructured":"American College of Chest Physicians\/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 20, 864\u2013874 (1992).","DOI":"10.1097\/00003246-199206000-00025"},{"key":"13346_CR40","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent, J. L. et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 22, 707\u2013710 (1996).","journal-title":"Intensive Care Med."},{"key":"13346_CR41","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson, M. E., Pompei, P., Ales, K. L. & MacKenzie, C. R. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J. Chronic Dis. 40, 373\u2013383 (1987).","journal-title":"J. Chronic Dis."},{"key":"13346_CR42","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/01.CCM.0000295317.97245.2D","volume":"36","author":"S Gando","year":"2008","unstructured":"Gando, S. et al. Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: Results of a multicenter, prospective survey. Crit. Care Med. 36, 145\u2013150 (2008).","journal-title":"Crit. Care Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13346-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13346-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13346-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T03:58:27Z","timestamp":1669348707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13346-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,3]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["13346"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-13346-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,3]]},"assertion":[{"value":"3 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Satoshi Gando reports receiving personal fees from Grifols outside the submitted work. Atsushi Shiraishi reports receiving personal fees from CSL Behring outside the submitted work. Other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9304"}}